Ironwood Pharmaceuticals Provides Third Quarter 2018 Investor Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Ironwood Pharma (IRWD) Misses Q3 EPS by 21c
November 6, 2018 8:12 AM ESTIronwood Pharma (NASDAQ: IRWD) reported Q3 EPS of ($0.38), $0.21 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $65.7 million versus the consensus estimate of $94.71 million.
For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.
... More